Nova Eye to Feature Several Presentations and Posters Related to iTrack Canaloplasty at 2024 ESCRS Annual Congress
Media Release General iTrack Molteno3 AlphaRET
2 Aug, 2024
iTrack™ Canaloplasty to be Featured at the 2024 Women in Ophthalmology (WIO) Summer Symposium
Media Release General iTrack Molteno3 AlphaRET
24 July, 2024
iTrack™ Canaloplasty to be Featured at the 2024 World Ophthalmology Congress (WOC)
Media Release General iTrack Molteno3 AlphaRET
24 July, 2024
iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
22 Mar, 2024
iTrack™ Canaloplasty to be Featured at the 2024 American Glaucoma Society (AGS) Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
23 Jan, 2024
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
Media Release General iTrack Molteno3 AlphaRET
1 Sept, 2023
iTrack™ Canaloplasty to be Featured at the Congress of German Ophthalmic Surgery (DOC) 2023
Media Release General iTrack Molteno3 AlphaRET
15 June, 2023
Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
Media Release General iTrack
19 Apr, 2022
iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting
Media Release General iTrack
12 Apr, 2022
Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board
Media Release General iTrack
31 Mar, 2022
For media enquires please contact:
Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com